Uncle Sam might sell off stake in Heritage Oaks
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Banks lead region’s stocks at midyear
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
First California faces more shareholder dissent
Investors who own 5.4 percent of First California Financial Group’s shares have joined the ranks of disgruntled stockholders after the bank snubbed a buyout offer from Los Angeles-based PacWest Bancorp. A letter dated May 23 from Loeb Offshore Management out of New York came through in the bank’s regulatory filings on May 29. Addressing Westlake Read More →
Teledyne to buy N.Y. firm for $291M
Thousand Oaks-based Teledyne Technologies has agreed to purchase a New York-based electronics testing instruments maker in a deal valued at $291 million. Teledyne, an industrial-defense conglomerate, is set to purchase Chestnut Ridge-based LeCroy Corp. for $14.30 a share, for a total of about $240 million. Stock options, appreciation rights and net debt push the deal Read More →
Minority group opposes PCBC-Union deal
The San Francisco African American Chamber of Commerce has told banking regulators that it opposes Union Bank’s $1.5 billion acquisition of Santa Barbara-based Pacific Capital Bancorp, according to the business newspaper for that region. The San Francisco Business Times reports that the chamber has told regulators it opposed the deal because it feels San Francisco-based Read More →
Where in the world do the Amgen jets go?
Kevin Sharer concluded his decade-long reign at the helm of the world’s largest biotechnology company on May 23, when he handed the CEO reins over to Robert Bradway. But the former chief executive of Thousand Oaks-based Amgen will continue to keep a leased office, secretary and other perks through the end of 2017, according to Read More →
